Cardiovascular disease test kit BIOT-YG-I, FLI-600

serumplasmawhole blood

Introduction: Lp-PLA2 is also known as platelet-activating factor acetylhydrolase (PAF-AH). The molecular weight is 45KDa. It is synthesized and secreted by mature macrophages and lymphocytes, and is regulated by inflammatory mediators. It hydrolyzes the phospholipids of low-density lipoproteins to produce pro-inflammatory substances lysolecithin and oxidized fatty acids, so it has the effect of promoting inflammation and promoting atherosclerosis. Lp-PLA2 is an independent cardiovascular disease risk predictor, and is not affected by other biological indicators. It also provides new evidence for the link between inflammation, atherosclerosis and cardiovascular disease.[1] 1.The Lp-PLA2 Studies Collaboration, Lancet 2010; 375: 1536–44. Advantage: Simple operation and fast response (10min) Clinical significance: 1.Markers of vascular endothelial inflammation 2.Initiated in the early stages of the vascular inflammation process 3.Not affected by other inflammatory diseases 4.It is a specific target for drug intervention and treatment of coronary heart disease Intended use: ICU, Respiratory Medicine, Cardiology